Robins Kaplan LLP Announces 2019 Executive Board

March 4, 2019

Robins Kaplan LLP announced today the firm’s 2019 Executive Board. Steven Schumeister has been re-elected to serve as Managing Partner of the firm.

The following partners have been re-elected to two-year board terms:

  • Jake Holdreith, Leader of the Health and Life Sciences Industry Group
  • Hollis Salzman, Assistant Managing Partner of the New York office and Co-Chair of the Antitrust and Trade Regulation Group
  • Steven Schumeister, Managing Partner of the firm
  • Ronald Schutz, Managing Partner of the New York office

Michael Collyard, Chair of the Ediscovery Group, and Peter Schmit, Chair of the Personal Injury and Medical Malpractice Group, have been appointed to one-year board terms.

The following partners will continue to serve on the Executive Board:

  • Tony Froio, Managing Partner of the Boston office
  • Tara Sutton, Chair of the Mass Tort Group

Related Publications

Fall 2021
Are All Fiduciaries Created Equal?
Erica Ramsey - The Robins Kaplan Spotlight, Vol. 6, No. 3
Fall 2021
Context Matters: Fiduciaries and the Rule Against Self-Dealing
Brendan Johnson, Tim Billion - The Robins Kaplan Spotlight, Vol. 6, No. 3
Fall 2021
Update on DOL Fiduciary Rule
Michael Reif - The Robins Kaplan Spotlight, Vol. 6, No. 3
September 28, 2021
Briefly: Federal appeals: How much notice is enough?
Stephen Safranski and Geoffrey Kozen - Minnesota Lawyer
Summer 2021
IATL President's Letter on Judicial Security
Roman Silberfeld - The Robins Kaplan Quarterly: Tackling Tough Business Litigation Matters
Back to Top